Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes

Research output: Contribution to journalReview articleAcademicpeer-review

23 Citations (Scopus)


Myelodysplastic syndromes (MDS) are a challenging group of diseases for clinicians and researchers, as both disease course and pathobiology are highly heterogeneous. In (suspected) MDS patients, multi-parameter flow cytometry can aid in establishing diagnosis, risk stratification and choice of therapy. This review addresses the developments and future directions of multi-parameter flow cytometry scores in MDS. Additionally, we propose an integrated diagnostic algorithm for suspected MDS.
Original languageEnglish
Pages (from-to)14-23
Number of pages10
Issue number1
Early online date2018
Publication statusPublished - 1 Jan 2019


  • Diagnosis
  • Flow cytometry
  • Myelodysplastic syndromes

Cite this